Arch Therapeutics, Inc. Quarterly Quick Ratio in % from Q2 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
The acid-test ratio, also called the quick ratio, is a metric used to see if a company is positioned to sell assets within 90 days to meet immediate expenses.
Summary
Arch Therapeutics, Inc. quarterly Quick Ratio history and growth rate from Q2 2020 to Q2 2024.
  • Arch Therapeutics, Inc. Quick Ratio for the quarter ending June 30, 2024 was 11.3 %, a 51.2% decline year-over-year.
Quick Ratio, Quarterly (%)
Quick Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 11.3 -11.9 -51.2% Jun 30, 2024
Q1 2024 12.6 -21.6 -63.1% Mar 31, 2024
Q4 2023 14.3 -40.3 -73.8% Dec 31, 2023
Q3 2023 18.3 -42.3 -69.8% Sep 30, 2023
Q2 2023 23.2 -46.6 -66.8% Jun 30, 2023
Q1 2023 34.2 -31.5 -47.9% Mar 31, 2023
Q4 2022 54.5 -2.09 -3.69% Dec 31, 2022
Q3 2022 60.7 -6.05 -9.07% Sep 30, 2022
Q2 2022 69.8 -9.91 -12.4% Jun 30, 2022
Q1 2022 65.7 -36.8 -35.9% Mar 31, 2022
Q4 2021 56.6 -89 -61.1% Dec 31, 2021
Q3 2021 66.7 -51.1 -43.4% Sep 30, 2021
Q2 2021 79.7 -11.5 -12.6% Jun 30, 2021
Q1 2021 103 Mar 31, 2021
Q4 2020 146 Dec 31, 2020
Q3 2020 118 Sep 30, 2020
Q2 2020 91.2 Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.